Table 3.
Univariable and multivariable analysis for predicting advanced pathological stage and high pathological grade PCa
| Advanced pathological stage (≥ pT3a or N1) | High pathological Gleason Score (≥4 + 3) | |||||||
|---|---|---|---|---|---|---|---|---|
| Crude OR | p | Multivariable | p | Crude OR | p | Multivariable | p | |
| Age, years | OR: 1.051 (CI: 1.010-1.094) | 0.014 | OR: 1.044 (CI: 0.997-1.094) | 0.006 | OR: 1.021 (CI: 0.984-1.060) | 0.268 | OR: 1.001 (CI: 0.961-1.044) | 0.949 |
| TRUS Volume, ml | OR: 0.994 (CI: 0.987-1.002) | 0.155 | OR: 0.993 (CI: 0.983-1.003) | 0.173 | OR: 0.997 (CI: 0.989-1.004) | 0.356 | OR: 0.998 (CI: 0.989-1.006) | 0.594 |
| PSA, ng/ml | OR: 1.068 (CI: 1.033-1.134) | 0.001 | OR: 1.121 (CI: 1.060-1.185) | 0.001 | OR: 1.038 (CI: 1.012-1.065) | 0.004 | OR: 1.064 (CI: 1.024-1.106) | 0.002 |
| BMI, kg/m2 | OR: 1.016 (CI: 0.945-1.092) | 0.673 | OR: 1.027 (CI: 0.957-1.102) | 0.459 | ||||
| MetS | OR: 2.439 (CI: 1.492-3.987) | 0.004 | OR: 2.697 (CI: 1.481-4.913) | 0.001 | OR: 1.886 (CI: 1.164-3.054) | 0.010 | OR: 1.880 (CI: 1.066-3.316) | 0.029 |
| Waist, cm | OR: 1.016 (CI: 0.990-1.043) | 0.218 | OR: 1.009 (CI: 0.984-1.034) | 0.494 | ||||
| Glycaemia, mg/dl | OR: 1.007 (CI: 0.996-1.018) | 0.203 | OR: 1.007 (CI: 0.997-1.018) | 0.181 | ||||
| Trygliceridemia, mg/dl | OR: 1.001 (CI: 0.997-1.005) | 0.565 | OR: 1.002 (CI: 0.998-1.005) | 0.423 | ||||
| HDL, mg/dl | OR: 1.001 (CI: 0.983-1.019) | 0.947 | OR: 0.992 (CI: 0.974-1.010) | 0.374 | ||||
| Hypertension | OR: 1.621 (CI: 0.987-2.662) | 0.056 | OR: 2.180 (CI: 1.330-3.575) | 0.002 | ||||
OR = Odds Ratio